The ratio of ADSCs to HSC-progenitors in adipose tissue derived SVF may provide the key to predict the outcome of stem-cell therapy

@inproceedings{Kilinc2018TheRO,
  title={The ratio of ADSCs to HSC-progenitors in adipose tissue derived SVF may provide the key to predict the outcome of stem-cell therapy},
  author={Mehmet Okyay Kilinc and Antonio F. Santidri{\'a}n and Ivelina Minev and Robert Toth and Dobrin Draganov and Duong Nguyen and Elliot Lander and Mark A Berman and Boris R. Minev and Aladar A. Szalay},
  booktitle={Clinical and Translational Medicine},
  year={2018}
}
BackgroundStromal vascular fraction (SVF) represents an attractive source of adult stem cells and progenitors, holding great promise for numerous cell therapy approaches. In 2017, it was reported that 1524 patients received autologous SVF following the enzymatic digestion of liposuction fat. The treatment was safe and effective and patients showed significant clinical improvement. In a collaborative study, we analyzed SVF obtained from 58 patients having degenerative, inflammatory, autoimmune… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 58 REFERENCES

Adipose-Derived Stem Cells as a Tool in Cell-Based Therapies

  • Archivum Immunologiae et Therapiae Experimentalis
  • 2016
VIEW 2 EXCERPTS